Targeting Glutamine Metabolism in Breast Cancer with AminooxyacetatePreethi Korangath, Saraswati Sukumar, Wei Wen Teo et al.|Clinical Cancer Research|2015Cited by 189
The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trialJason J. Luke, Paul A. Moore, Manish R. Patel et al.|Nature Medicine|2023Cited by 135
Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific ApproachJennifer Y. Sheng, Karen L. Smith, Cesar A. Santa‐Maria et al.|JCO Oncology Practice|2020Cited by 67
Optimizing Radiation Therapy to Boost Systemic Immune Responses in Breast Cancer: A Critical Review for Breast Radiation OncologistsAlice Y. Ho, Gaorav P. Gupta, Jean L. Wright et al.|International Journal of Radiation Oncology*Biology*Physics|2020Cited by 47
The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote TrialCesar A. Santa‐Maria, Vered Stearns, Janelle W. Coughlin et al.|Clinical Cancer Research|2020Cited by 45